Drug – bio-affecting and body treating compositions – Lymphokine – Interleukin
Patent
1995-09-20
1999-01-26
Hutzell, Paula K.
Drug, bio-affecting and body treating compositions
Lymphokine
Interleukin
514 12, 514 2, A61K 3820
Patent
active
058635297
ABSTRACT:
A method of suppressing demyelination of the central nervous system is disclosed. The method comprises administering a therapeutically effective amount of Interleukin-6 or an analog thereof to a mammal. Methods of treating multiple sclerosis and a related article of manufacture are also disclosed.
REFERENCES:
patent: 5437863 (1995-08-01), Williams et al.
Savino et al. Proc. Natl. Acad. Sci USA 90 (1993) 4067-4071.
Ehlers et al. Annals New York Acad. Sci. 762(1995) 400-402.
Li et al. J. of Biological Chemistry 268 (1993) 22377-22384.
Lee Beek et al. J. of Biological Chemistry 267 (1992) 14832-14838.
Hammacher et al. Protein Science 3 (1994) 2280-2293.
Fontaine et al. Eur. J. Biochem. 211 (1993) 749-755.
Rodriguez et al. J. Immunol. 153 (1994) 3811-3812.
Cohen. Science 270 (1995) 908.
Desquenne -Clark et al. PNAS 88 (1991) 7219-7223.
Osband et al. Immunology Today 11 (1990) 193-195.
Rudinger. In "Peptide Hormones", ed. J.A Parsons (Jun. 1976) University Park Press, Baltimore, pp. 1-7.
Porrini et al. Cell Immunol. 157 (1994) 428-438.
Dal Canto et al. Ann. Neurol 11:109 (1982).
Compston, A. and Sadovnick, A.D., Curr. Opin. Neurol. Neurosurg. 5:175 (1992).
Akira, et al., IL-6 and NF-IL6 in Acute-Phase Response and Viral Infection, Immunological Reviews, No. 127, pp.25-50 (1992)
Carter, et al., The Immunopathology of Multiple Sclerosis, Current Opinion in Neurology and Neurosurgery, 4:186-190 (1991).
Frei, et al., Interleukin-6 is Elevated in Plasma in Multiple Sclerosis, Joural of Neuroimmunology 31:147-153 (1991).
Frei, et al., On the Cellular Source and Junction of Interleukin-6 Produced in the Central Nervous System in Viral Diseases, Eur. J. Immunol., 19:689-694 (1989)
Gijbels, et al., Interleukin 6 Production in the Central Nervous System During Experimental Autoimmune Encephalomyelitis, Eur. J. Immunol., 20:233-235 (1990).
Henke, et al., Coxsackievirus B3-Induced Production of Tumor Necrosis Factor-.alpha., IL-1.beta., and IL-6 in Human Monocytes, The Journal of Immunology, vol. 148, 2270-2277, No. 7, Apr. 1, 1992.
Joseph, et al., Interleukin-6 Induction in Vitro in Mouse Brain Endothelial Cells and Astrocytes by Exposure to Mouse Hepatitis Virus (MHV-4, JHM),Journal of Neuroimmunology, 42:47-52 (1993).
Maimone, et al., Norepinephrine and Vasoactive Intestinal peptide Induce IL--6 Secretion by Astrocytes: Synergism With IL-1.beta. and TNF.alpha., Journal of Neuroimmunology, 47:73-82 (1993).
Patick, et al., Major Histocompatability Complex-Conferred Resistance to Theiler's Virus-Induced Demyelinating Disease is Inherited as a Dominant Trait in B10 Congenic Mice, J. of Virology, 64:5570-76(1990).
Paya, et al., Inhibition of Theiler's Virus-Induced Demyelination in vivo by Tumor Necrosis Factor Alpha, International Immunology, vol. 2, No. 9, pp. 909-913 (1990).
Rodriguez, Moses, Multiple Sclerosis: Basic Concepts and Hypothesis, Mayo Clin. Proc, 64:570-6 (1989).
Rodriguez, Moses,Mechanisms of Virus-Induced Demyelination and Remyelination.sup..alpha., Advances in Neuroimmunology, vol. 540 of the Annals of the New York Academy of Sciences,pp. 240-251 (Nov. 28, 1988).
Rodriguez, et al., Role of T Cell Receptor V.beta. Genes in Theiler's Virus-Induced Demyelination of Mice, The Journal of Immunology, 148:921-927 (1992).
Rodriguez, et al., Theiler'Murine Encephalomyelitis: A Model of Demyelination and Persistence of Virus, CRC Critical Reviews in Immunology, vol. 7, Issue 4, pp. 325-365 (1987).
Rodriguez, et al., Expression of Human HLA-B27 Transgene Alters Sussceptibility to Murine Theiler's Virus-Induced Demyelination, The Journal of Immunology, 146:2596-2602 (1991).
Sebire, et al., In Vitro Production of IL-6, IL-1.beta., and Tumor Necrosis Factor-.alpha. by Human Embryonic Microglial and Neural Cells, The Journal of Immunology, 150:1517-1523 (1993).
Hayes Robert C.
Hutzell Paula K.
Mayo Foundation for Medical Education and Research
LandOfFree
Suppression of demyelination by interleukin-6 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Suppression of demyelination by interleukin-6, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Suppression of demyelination by interleukin-6 will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1447985